Enoxaparin sodium NDC 0955-1016

Product information

Brand name (proprietary)

Enoxaparin sodium

Generic name (nonproprietary)

enoxaparin sodium

Active ingredients

Enoxaparin sodium — 300 mg/3mL

Dosage form

Injection

Route

Subcutaneous

Labeler

Sanofi-Aventis U.S. LLC

Product type

Prescription drug

Marketing category

NDA authorized genericApplication NDA 020164

Marketing start

Oct 3, 2011

Listing expires

Dec 31, 2027

Other FDA classes

Low-Molecular-Weight (Chemical structure)

Identifiers

Product ID 0955-1016_8f06a411-badb-483f-852d-8e6124acfa44SPL ID 8f06a411-badb-483f-852d-8e6124acfa44

Pharmacologic class

Low Molecular Weight Heparin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400955101601 followed by a unit qualifier and the quantity Copy

Package 00955-1016-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under NDA 020164

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

Showing 20 of 39.